{"id":"https://openalex.org/W3082863523","doi":null,"title":"Angiopoietin/TIE receptor signaling pathway : characterization of the Angiopoietin-2 lymphedema patient variants","display_name":"Angiopoietin/TIE receptor signaling pathway : characterization of the Angiopoietin-2 lymphedema patient variants","alternate_titles":[],"publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W3082863523","mag":"3082863523"},"language":"en","primary_location":{"id":"pmh:oai:helda.helsinki.fi:10138/317414","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10138/317414","pdf_url":null,"source":{"id":"https://openalex.org/S4406922691","display_name":"Helda - University of Helsinki Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"pro gradu -tutkielmat"},"parent_works":[],"lineage":["https://openalex.org/W3082863523"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082290355","display_name":"Basma Ragab","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Basma Ragab","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5082290355"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12426","display_name":"Lymphatic Disorders and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiopoietin-2","display_name":"angiopoietin-2","score":0.9419999718666077},{"id":"https://openalex.org/keywords/tie2-receptor","display_name":"Tie2 receptor","score":0.7200000286102295},{"id":"https://openalex.org/keywords/lymphedema","display_name":"lymphedema","score":0.9490000009536743},{"id":"https://openalex.org/keywords/lymphangiogenesis","display_name":"lymphangiogenesis","score":0.8610000014305115},{"id":"https://openalex.org/keywords/lymphatic-development","display_name":"lymphatic development","score":0.7310000061988831},{"id":"https://openalex.org/keywords/dominant-negative","display_name":"dominant negative effect","score":0.7120000123977661},{"id":"https://openalex.org/keywords/receptor-phosphorylation","display_name":"receptor phosphorylation","score":0.7799999713897705},{"id":"https://openalex.org/keywords/endothelial-cells","display_name":"endothelial cells","score":0.6869999766349792},{"id":"https://openalex.org/keywords/cell-adhesion","display_name":"cell adhesion","score":0.7950000166893005}],"concepts":[{"id":"https://openalex.org/C85219853","wikidata":"https://www.wikidata.org/wiki/Q4763284","display_name":"Angiopoietin receptor","level":3,"score":0.560329020023346},{"id":"https://openalex.org/C2781392513","wikidata":"https://www.wikidata.org/wiki/Q916398","display_name":"Lymphedema","level":4,"score":0.5068455338478088},{"id":"https://openalex.org/C2779094623","wikidata":"https://www.wikidata.org/wiki/Q539710","display_name":"Angiopoietin","level":4,"score":0.4738926291465759},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.45980918407440186},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4427727460861206},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.44202321767807007},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37084221839904785},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3121766746044159},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3044010102748871},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24563312530517578},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15559887886047363},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.143220454454422},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.1261148750782013},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.09686541557312012}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:helda.helsinki.fi:10138/317414","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10138/317414","pdf_url":null,"source":{"id":"https://openalex.org/S4406922691","display_name":"Helda - University of Helsinki Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"pro gradu -tutkielmat"},{"id":"mag:3082863523","doi":null,"is_oa":false,"landing_page_url":"https://helda.helsinki.fi/handle/10138/317414","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9074000120162964}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4411258266","https://openalex.org/W3083896784","https://openalex.org/W4399205877","https://openalex.org/W4283644123","https://openalex.org/W336237379","https://openalex.org/W2007326744","https://openalex.org/W4414458177","https://openalex.org/W105959312","https://openalex.org/W2111191070","https://openalex.org/W2139332469"],"abstract_inverted_index":{"Lymphedema":[0,30],"is":[1,13,70,81,104,233],"a":[2,127,221],"progressive":[3],"disease,":[4],"resulting":[5,95],"from":[6],"abnormalities":[7],"of":[8,17,22,45,52,64,67,86,129,144,164],"the":[9,23,42,48,53,62,71,84,142,145,214,218,237,240,243],"lymphatic":[10,87,93,180],"system.":[11,73],"It":[12,74],"characterized":[14],"by":[15,107],"swelling":[16],"one":[18],"or":[19],"more":[20],"parts":[21],"body,":[24],"due":[25],"to":[26,140],"impaired":[27],"lymph":[28,119],"transport.":[29],"has":[31,75,134,171],"no":[32],"definitive":[33],"treatment":[34,63],"and":[35,99,121,147,154,160,179,188,195,207,212,228],"it":[36],"can":[37],"have":[38],"serious":[39],"effects":[40],"on":[41],"patients'":[43],"quality":[44],"life.":[46],"However,":[47],"recent":[49],"knowledge":[50],"expansion":[51],"molecular":[54],"mechanisms":[55,69],"regulating":[56],"lymphangiogenesis":[57],"provides":[58],"new":[59],"possibilities":[60],"for":[61,83],"lymphedema.":[65,161],"One":[66],"these":[68,165],"angiopoietin-TIE":[72],"been":[76,135,173],"shown":[77],"recently":[78],"that":[79,186,204],"ANG2":[80,149,190],"essential":[82],"formation":[85],"vasculature.":[88],"Mice":[89],"ANG2-deletion":[90],"caused":[91],"widespread":[92],"dysfunction,":[94],"in":[96,113,116,137,156,167,175,198,225,239],"subcutaneous":[97],"edema":[98],"chylous":[100],"ascites.":[101],"Lymphatic":[102],"development":[103],"also":[105,172,202],"regulated":[106],"TIE1":[108,196,229],"receptor,":[109],"as":[110],"its":[111],"deletion":[112],"mice":[114],"resulted":[115],"malformed":[117],"jugular":[118],"sacs":[120],"severe":[122],"edema.":[123],"In":[124],"this":[125],"study,":[126],"model":[128],"autocrine":[130],"TIE":[131,157],"receptor":[132,158,230],"activation":[133,197,231],"established":[136],"endothelial":[138,181,199],"cells":[139],"investigate":[141],"effect":[143,224],"WT-ANG2":[146,187,216],"four":[148],"mutants":[150,209,244],"(T299M,":[151],"N304K,":[152,205],"C435S":[153,206],"R492Q)":[155],"phosphorylation":[159],"The":[162,183],"role":[163],"variants":[166,191],"direct":[168],"cell":[169],"adhesion":[170],"investigated":[174],"vitro":[176],"using":[177],"HeLa":[178],"cells.":[182,200],"findings":[184],"revealed":[185],"soluble":[189],"induced":[192],"both":[193,226],"TIE2":[194,227],"We":[201],"found":[203],"R492Q":[208],"are":[210],"secretion-deficients":[211],"retain":[213],"co-expressed":[215],"inside":[217],"cells,":[219],"causing":[220],"dominant":[222],"negative":[223],"which":[232],"likely":[234],"associated":[235],"with":[236],"lymphedema":[238],"patients":[241],"where":[242],"were":[245],"identified.":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3082863523","counts_by_year":[],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2020-09-08T00:00:00"}
